1
|
Chan C, Feng A, Waters C, Nimaroff M, Acholonu U. 8715 Enhancing Quality of Recovery and Satisfaction in Minimally Invasive Gynecologic Surgery - Utility of Structured Perioperative Education. J Minim Invasive Gynecol 2022. [DOI: 10.1016/j.jmig.2022.09.464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
2
|
Li H, Cao M, Feng A, Cai H. Silicosis: enlarged cervical lymph nodes, pericardial effusion and lung abnormalities. Occup Med (Lond) 2021; 72:415-419. [PMID: 34897505 DOI: 10.1093/occmed/kqab178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Silicosis is an occupational lung parenchymal disease caused by inhaling silica. It requires differentiation from a malignant tumour and granulomatous disease. We describe the case of a woman with silicosis who exhibited enlargement of bilateral cervical lymph nodes, pericardial effusion and lung abnormalities. She was diagnosed with silicosis based on histological examination of a resected cervical lymph node, lung tissue biopsy and history of silica exposure. She underwent glucocorticoid therapy during hospitalization. The lung abnormalities, enlarged cervical lymph nodes and pericardial effusion were ameliorated by glucocorticoid therapy, but she relapsed shortly thereafter. In conclusion, silicosis with cervical lymph node enlargement and pericardial effusion is rare and should be differentiated from a malignant tumour and granulomatous disease. Some patients may respond well to steroids in the short term.
Collapse
Affiliation(s)
- H Li
- Division of Pulmonary and Critical Care Medicine, The Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
| | - M Cao
- Division of Pulmonary and Critical Care Medicine, The Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
| | - A Feng
- Division of Pathology, The Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
| | - H Cai
- Division of Pulmonary and Critical Care Medicine, The Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
| |
Collapse
|
3
|
Wang J, Liu Z, Feng A, Tian K, Wei Y, Wang W, Pan Q, Zhang L, Wang F, Zhang S. P60.04 The Association of Patient HLA Class I Genotype and Genomic Alterations of Non-Small Cell Lung Cancer. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
4
|
Ballantyne C, Banach M, Bays H, Catapano A, Laufs U, Stroes E, Bloedon L, Feng A, Robinson P, Ray K. Long-term safety and efficacy of bempedoic acid in patients at high risk of atherosclerotic cardiovascular disease: results from the CLEAR Harmony open-label extension study. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3344] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Bempedoic acid (BA) is an oral first-in-class, ATP-citrate lyase inhibitor that lowers low-density lipoprotein cholesterol (LDL-C) levels in adults with hypercholesterolemia. In the phase 3 CLEAR Harmony study (NCT02666664, n=2230), BA 180 mg for 52 weeks significantly lowered LDL-C at week 12 compared with placebo and was maintained for 52 weeks in hypercholesterolemic patients with atherosclerotic cardiovascular disease (ASCVD) and/or heterozygous familial hypercholesterolemia (HeFH) on stable, maximally tolerated statins.
Purpose
To report long-term safety, tolerability, and efficacy of BA from the CLEAR Harmony open-label extension (OLE) study (NCT03067441).
Methods
After completing the 52-week placebo-controlled CLEAR Harmony study, patients immediately entered the OLE and received BA for 78 weeks, followed by a 4-week washout period; the potential cumulative exposure to BA was 2.5 years. The primary endpoint was long-term safety of BA in the OLE.
Results
A total of 1462 patients enrolled in the OLE (BA n=970; placebo n=492 from CLEAR Harmony). At OLE baseline, mean (SD) age was 66.9 (8.7) years, 73.9% were male, 96.3% had ASCVD, 3.7% had HeFH with or without ASCVD, and all were receiving statins (93.5% moderate or high intensity). At baseline of CLEAR Harmony, patients had mean (SD) LDL-C of 102.9 (29.9) mg/dL (BA) and 99.0 (24.2) mg/dL (placebo). The majority of OLE patients (86.2%, n=1260) completed 78 weeks of BA treatment. At week 12 and 78 of OLE treatment, respectively, mean LDL-C lowering from CLEAR Harmony baseline was –14.9% and –14.4%. A total of 1143 patients (78.2%) reported a treatment-emergent adverse event (TEAE), and 299 (20.5%) reported a serious TEAE. TEAEs of special interest, determined by the therapeutic area or prior observations in preclinical or early clinical studies, occurred at similar rates as CLEAR Harmony (creatine kinase elevations, 1.8%; gout, 2.6%; hepatic enzyme elevations, 2.0%; hypoglycemia, 1.2%; muscular disorders, 8.5%; neurocognitive disorders, 0.9%; new onset/worsening diabetes mellitus, 5.5%; renal disorders, 2.8%) with biochemical changes that were stable over the course of the study and approached baseline levels after treatment discontinuation. Overall, 114 patients (7.8%) reported a TEAE leading to discontinuation of BA (most common: myalgia [0.6%], muscle spasm [0.5%]).
Conclusion
Durable lipid lowering was observed through 78 weeks of BA treatment and patient adherence to BA therapy was high (86.2%). Overall safety during the OLE was similar to results reported in the 52-week-long CLEAR Harmony study and the overall BA phase 3 clinical program, with no new safety findings.
Funding Acknowledgement
Type of funding source: Private company. Main funding source(s): Esperion Therapeutics, Inc., funded the research for this study and provided writing support for this abstract. Medical writing assistance was provided by Agnella Izzo Matic, PhD, CMPP, and Kelly M Cameron, PhD, CMPP, of JB Ashtin.
Collapse
Affiliation(s)
- C.M Ballantyne
- Baylor College of Medicine, Department of Medicine, Houston, United States of America
| | - M Banach
- Medical University of Lodz and Polish Mother's Memorial Hospital Research Institute, Department of Hypertension, Lodz, Poland
| | - H.E Bays
- Louisville Metabolic and Atherosclerosis Research Center, Louisville, United States of America
| | - A.L Catapano
- University of Milan and IRCCS Multimedica, Department of Pharmacological and Biomolecular Sciences, Milan, Italy
| | - U Laufs
- Universitätsklinikum Leipzig, Klinik und Poliklinik für Kardiologie, Leipzig, Germany
| | - E.S.G Stroes
- Academic Medical Center, Department of Vascular Medicine, Amsterdam, Netherlands (The)
| | - L Bloedon
- Esperion Therapeutics, Inc., Ann Arbor, United States of America
| | - A Feng
- Esperion Therapeutics, Inc., Ann Arbor, United States of America
| | - P Robinson
- Esperion Therapeutics, Inc., Ann Arbor, United States of America
| | - K.K Ray
- Imperial College London, Department of Primary Care and Public Health, London, United Kingdom
| |
Collapse
|
5
|
Ray K, Bakris G, Banach M, Catapano A, Duell P, Mancini G, Bloedon L, Feng A, Gotto Jr A. Effect of bempedoic acid on uric acid and gout in 3621 patients with hypercholesterolemia: pooled analyses from phase 3 trials. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Bempedoic acid (BA), an oral ATP-citrate lyase inhibitor, significantly lowers low-density lipoprotein cholesterol levels in patients with hypercholesterolemia. In clinical trials of BA, small mean increases in uric acid have been reported. BA weakly inhibits organic anion transporter 2 (OAT2) in vitro, which may account for small elevations in serum uric acid.
Purpose
To assess uric acid levels and incidence of gout with BA treatment.
Methods
Data were pooled from 4 randomized (2:1), double-blind studies of BA (180 mg daily) vs placebo for 12 weeks to 52 weeks in patients with hypercholesterolemia on stable background lipid-lowering therapy. Safety assessments included adverse events of special interest (elevation in uric acid levels, gout) and laboratory assessments.
Results
A total of 2424 patients treated with BA and 1197 patients on placebo were included in this analysis. Mean (SD) baseline uric acid levels were 6.0 (1.4) mg/dL for both groups. History of gout was reported by 5.2% (127/2424) and 5.8% (69/1197) in the BA and placebo groups, respectively. At week 12, mean (SD) serum uric acid levels (% change from baseline) increased from baseline with BA treatment by 0.82 (0.97) mg/dL (14.8%) vs –0.02 (0.82) mg/dL (0.67%) for placebo. Elevations in serum uric acid levels typically occurred within the first 4 weeks of treatment, remained stable during treatment, and returned to baseline after treatment discontinuation. Gout was reported in 1.4% (BA) and 0.4% (placebo) of patients, and hyperuricemia was reported in 1.7% (BA) and 0.6% (placebo) of patients. Other potential clinical consequences of elevated uric acid levels (eg, events associated with nephrolithiasis), were similar between groups (0.7% vs 0.8%). In both groups, patients who reported gout during the studies were more likely to have a medical history of gout or elevated baseline uric acid levels (Table). Few patients discontinued treatment due to gout (n=1, <0.1% [BA]) or uric acid increases (n=2, <0.1% [BA]).
Conclusion
Mean increases in uric acid levels were small, remained stable while patients continued to receive treatment, were infrequently associated with AEs, and were reversible on discontinuation of BA
Funding Acknowledgement
Type of funding source: Private company. Main funding source(s): Esperion Therapeutics funded the research for this study and provided writing support for this abstract. Medical writing assistance was provided by Agnella Izzo Matic, PhD, CMPP, and Kelly M Cameron, PhD, CMPP, of JB Ashtin.
Collapse
Affiliation(s)
- K.K Ray
- Imperial College London, Department of Primary Care and Public Health, London, United Kingdom
| | - G.L Bakris
- University of Chicago Medicine, American Heart Association Comprehensive Hypertension Center, Chicago, United States of America
| | - M Banach
- Medical University of Lodz and Polish Mother's Memorial Hospital Research Institute, Department of Hypertension, Lodz, Poland
| | - A Catapano
- University of Milan and IRCCS Multimedica, Department of Pharmacological and Biomolecular Sciences, Milan, Italy
| | - P.B Duell
- Oregon Health and Science University, Knight Cardiovascular Institute, School of Medicine, Portland, United States of America
| | - G.B.J Mancini
- University of British Columbia, Department of Medicine, Division of Cardiology, Vancouver, Canada
| | - L Bloedon
- Esperion Therapeutics Inc, Ann Arbor, United States of America
| | - A Feng
- Esperion Therapeutics Inc, Ann Arbor, United States of America
| | - A.M Gotto Jr
- Weill Cornell Medical College, Cardiovascular Unit, New York, United States of America
| |
Collapse
|
6
|
Abstract
Since cases first emerged in December 2019, COVID‐19 (a type of coronavirus) has rapidly become pandemic. This fast‐tracked paper (published quickly) from China on COVID‐19 is written by dermatologists at the epicentre of the outbreak in Wuhan. Dermatology clinic staff may be at risk because protective equipment is not routinely available, and skin lesions might possibly transmit the virus indirectly. These authors suggest preventive measures based on experience in this and previous coronavirus outbreaks. Online consultation for non‐urgent patients reduces the numbers of patients attending clinics. Nurse‐led triage, to identify patients with possible COVID‐19, at the entrances of hospital and skin clinics directs patients with a cough or fever to a specific COVID‐19 area and a dermatologist is consulted if the fever might be related to skin disease. Clinic staff wear N95 masks and observe hand hygiene during consultations. Patients are admitted to a ward only if routine blood tests and chest CT scans exclude COVID‐19. Triage will not detect patients who are showing no symptoms but who are developing the disease, so the hospital should provide an on‐call expert team to discuss inpatients suspected or diagnosed with COVID‐19 and refer them to radiology, respiratory or intensive care colleagues as required. Confirmed cases are managed following local policies. Skin disorders in COVID‐19 inpatients can usually be managed remotely using photographs, email and teleconferencing. If necessary a multidisciplinary team (a team of medical staff from different specialties) can meet in the clean area of the isolation ward. If the dermatologist must see the patient, all records should be provided in advance to minimise exposure time. With these precautions, as of 20th February 2020 no infected patients were detected in the Wuhan Dermatology Department. This is a summary of the study: Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department Linked Article: Tao et al. Br J Dermatol 2020; 182:1477–1478
Collapse
|
7
|
Workman AD, Xiao R, Feng A, Gadkaree SK, Quesnel AM, Bleier BS, Scangas GA. Suction mitigation of airborne particulate generated during sinonasal drilling and cautery. Int Forum Allergy Rhinol 2020; 10:1136-1140. [PMID: 32779883 PMCID: PMC7323193 DOI: 10.1002/alr.22644] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Revised: 06/15/2020] [Accepted: 06/16/2020] [Indexed: 01/21/2023]
Abstract
Background Coronavirus disease 2019 (COVID‐19) has significantly impacted endonasal surgery, and recent experimentation has demonstrated that sinonasal drilling and cautery have significant propensity for airborne particulate generation immediately adjacent to the surgical field. In the present investigation, we assessed nasopharyngeal suctioning as a mitigation strategy to decrease particulate spread during simulated endonasal surgical activity. Methods Airborne particulate generation in the 1‐µm to 10‐µm range was quantified with an optical particle sizer in real‐time during cadaveric‐simulated anterior and posterior endonasal drilling and cautery conditions. To test suction mitigation, experiments were performed both with and without a rigid suction placed in the contralateral nostril, terminating in the nasopharynx. Results Both anterior (medial maxillary wall and nasal septum) and posterior (sphenoid rostrum) drilling produced significant particulate generation in the 1‐µm to 10‐µm range throughout the duration of drilling (p < 0.001) without the use of suction, whereas nasopharyngeal suction use eliminated the detection of generated airborne particulate. A similar effect was seen with nasal cautery, with significant particle generation (p < 0.001) that was reduced to undetectable levels with the use of nasopharyngeal suction. Conclusion The use of nasopharyngeal suctioning via the contralateral nostril minimizes airborne particulate spread during simulated sinonasal drilling and cautery. In the era of COVID‐19, this technique offers an immediately available measure that may increase surgical safety.
Collapse
Affiliation(s)
- Alan D Workman
- Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA.,Harvard Medical School, Boston, MA
| | - Roy Xiao
- Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA.,Harvard Medical School, Boston, MA
| | - Allen Feng
- Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA.,Harvard Medical School, Boston, MA
| | - Shekhar K Gadkaree
- Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA.,Harvard Medical School, Boston, MA
| | - Alicia M Quesnel
- Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA.,Harvard Medical School, Boston, MA
| | - Benjamin S Bleier
- Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA.,Harvard Medical School, Boston, MA
| | - George A Scangas
- Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA.,Harvard Medical School, Boston, MA
| |
Collapse
|
8
|
Tao J, Song Z, Yang L, Huang C, Feng A, Man X. Emergency management for preventing and controlling nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department. Br J Dermatol 2020; 182:1477-1478. [PMID: 32141058 PMCID: PMC9619451 DOI: 10.1111/bjd.19011] [Citation(s) in RCA: 51] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Plain language summary available online
Collapse
Affiliation(s)
- J. Tao
- Department of Dermatology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China
- Hubei Engineering Research Center for Skin Repair and Theranostics Wuhan 430022 China
| | - Z. Song
- Department of Dermatology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China
- The Second Clinical Medical College Chongqing Medical University Chongqing 400010 China
| | - L. Yang
- Department of Dermatology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China
- Hunan Normal University School of Medicine Changsha 410013 Hunan China
| | - C. Huang
- Department of Dermatology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China
- Hubei Engineering Research Center for Skin Repair and Theranostics Wuhan 430022 China
| | - A. Feng
- Department of Dermatology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China
- Hubei Engineering Research Center for Skin Repair and Theranostics Wuhan 430022 China
| | - X. Man
- Department of Dermatology The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou 310009 Zhejiang China
| |
Collapse
|
9
|
Lee E, Ko L, Feng A, Bishop S. HEALTHY EATING HEALTHY AGING: COMMUNITY-BASED INTERVENTION PROGRAM FOR OLDER ASIAN AMERICAN AND PACIFIC ISLANDERS. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.1716] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- E Lee
- National Asian Pacific Center on Aging
| | - L Ko
- Fred Hutchinson Cancer Research Center
| | - A Feng
- National Asian Pacific Center on Aging
| | - S Bishop
- Fred Hutchinson Cancer Research Center
| |
Collapse
|
10
|
Flanagan S, Feng A, Young S, Hunter D. 3:27 PM Abstract No. 364 Recanalization of chronic visceral venous occlusions. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
11
|
Palmerini E, Blay JY, Le Cesne A, Reichardt P, Rutkowski P, Gelderblom H, Grimer R, Feng A, Jandial D, Chawla S. Long-term efficacy of denosumab in giant cell tumor of bone: Results of an open-label phase 2 study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx440.071] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Clark JH, Feng A, Harun A, Brown G, Francis HW. Secondary Acquired Cholesteatoma: Presentation and Tympanoplasty Outcomes. Otol Neurotol 2016; 37:902-7. [PMID: 27273390 DOI: 10.1097/mao.0000000000001100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE Comparing the clinical features and surgical outcomes of patients undergoing tympanoplasty for secondary acquired cholesteatoma (SAC) versus non-complicated tympanic membrane perforation (TMP). STUDY DESIGN Retrospective patient review. SETTING Tertiary-care, academic center. PATIENTS All 41 patients with diagnosis of SAC confirmed at surgery between January 1, 2007 and June 30, 2014, and an age-matched cohort consisting of patients with TMP. INTERVENTION(S) Tympanoplasty using either medial or lateral graft techniques. MAIN OUTCOME MEASURE(S) Resolution of perforation, SAC, and symptoms. RESULTS Comparison between the two cohorts failed to reveal significant differences in otologic symptomology, or presentation. There was no significant difference in the resolution of SAC (p = 0.7) between the medial and lateral tympanoplasty techniques. Both techniques also had similar rates of success in the TMP cohort. The medial graft technique was significantly (p = 0.008) more likely to result in a successfully repaired tympanic membrane in the TMP cohort compared with the SAC cohort. The Lateral graft technique demonstrated no significant difference in the likelihood of TMP and SAC resolution. CONCLUSION The presentation of SAC is similar to that of TMP despite being a separate clinical entity. A clinician's ability to distinguish the two is important to mitigate the destructive potential of untreated SAC and correctly council patients on tympanoplasty success rates. This study was unable to demonstrate a significant difference in disease control between the medial and lateral tympanoplasty techniques, although potential advantages of each technique are discussed.
Collapse
Affiliation(s)
- James H Clark
- *Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland †Department of Otolaryngology, University of the West Indies, Kingston, Jamaica, West Indies
| | | | | | | | | |
Collapse
|
13
|
Rook M, Murrell J, Feng A, Schnitzler A, Verma A, Aysola M, Lawson T, Philbrick K, Punreddy S. Large Scale Manufacturing Solutions for Mesenchymal Stem Cells. Cytotherapy 2015. [DOI: 10.1016/j.jcyt.2015.03.580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
14
|
Wang S, Luo Y, Feng A, Li T, Yang X, Nofech-Mozes R, Yu M, Wang C, Li Z, Yi F, Liu C, Lu WY. Ethanol induced impairment of glucose metabolism involves alterations of GABAergic signaling in pancreatic β-cells. Toxicology 2014; 326:44-52. [PMID: 25456265 DOI: 10.1016/j.tox.2014.10.005] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2014] [Revised: 10/09/2014] [Accepted: 10/10/2014] [Indexed: 01/02/2023]
Abstract
Alcohol overindulgence is a risk factor of type 2 diabetes mellitus. However, the mechanisms by which alcohol overindulgence damages glucose metabolism remain unclear. Pancreatic islet β-cells are endowed with type-A γ-aminobutyric acid receptor (GABAAR) mediated autocrine signaling mechanism, which regulates insulin secretion and fine-tunes glucose metabolism. In neurons GABAAR is one of the major targets for alcohol. This study investigated whether ethanol alters glucose metabolism by affecting GABAAR signaling in pancreatic β-cells. Blood glucose level of test mice was measured using a blood glucose meter. Insulin secretion by the pancreatic β-cell line INS-1 cells was examined using a specific insulin ELISA kit. Whole-cell patch-clamp recording was used to evaluate GABA-elicited current in INS-1 cells. Western blot and immunostaining were used to measure the expression of GABAAR subunits in mouse pancreatic tissues or in INS-1 cells. Intraperitoneal (i.p.) administration of ethanol (3.0g/kg body weight) to mice altered glucose metabolism, which was associated with decreased expression of GABAAR α1- and δ- subunits on the surface of pancreatic β-cells. Acute treatment of cultured INS-1cells with ethanol (60mM) decreased the GABA-induced current and reduced insulin secretion. In contrast, treating INS-1 cells with GABA (100μM) largely prevented the ethanol-induced reduction of insulin release. Importantly, pre-treating mice with GABA (i.p., 1.5mg/kg body weight) partially reversed ethanol-induced impairment of glucose homeostasis in mice. Our data suggest a novel role of pancreatic GABA signaling in protecting pancreatic islet β-cells from ethanol-induced dysfunction.
Collapse
Affiliation(s)
- Shuanglian Wang
- Department of Physiology, Shandong University School of Medicine, Jinan, Shandong, PR China
| | - Yan Luo
- Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada
| | - Allen Feng
- Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada; Robarts Research Institute, University of Western Ontario, London, ON, Canada
| | - Tao Li
- Department of Physiology, Shandong University School of Medicine, Jinan, Shandong, PR China
| | - Xupeng Yang
- Department of Physiology, Shandong University School of Medicine, Jinan, Shandong, PR China
| | - Roy Nofech-Mozes
- Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada; Robarts Research Institute, University of Western Ontario, London, ON, Canada
| | - Meng Yu
- Department of Physiology, Shandong University School of Medicine, Jinan, Shandong, PR China
| | - Changhui Wang
- Department of Physiology, Shandong University School of Medicine, Jinan, Shandong, PR China
| | - Ziwei Li
- Department of Physiology, Shandong University School of Medicine, Jinan, Shandong, PR China
| | - Fan Yi
- Department of Pharmacology, Shandong University School of Medicine, Jinan, Shandong, PR China
| | - Chuanyong Liu
- Department of Physiology, Shandong University School of Medicine, Jinan, Shandong, PR China.
| | - Wei-Yang Lu
- Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada; Robarts Research Institute, University of Western Ontario, London, ON, Canada.
| |
Collapse
|
15
|
Spigel D, Hirsch F, De Boer R, Natale R, Crawford J, Weiss G, Glaspy J, Feng A, Braun A, Jain R. A Phase 2, Randomized, Double-Blind, Multicenter Trial of Denosumab in Combination with Chemotherapy As First-Line Treatment of Metastatic Non-Small Cell Lung Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu349.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
16
|
Ferrari S, Rutkowski P, Grimer R, Stalley P, Dijkstra S, Pienkowski A, Vaz G, Seeger L, Feng A, Bach B. Assessment of Surgical Downstaging in an Open-Label Phase 2 Trial of Denosumab in Patients with Giant Cell Tumor of Bone. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu354.8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
17
|
Mullins DN, Abdel-Rasoul M, Querry J, Akuma D, Feng A, Shapiro CL, Macrae E. Abstract P4-12-20: Clinical outcomes of patients with recurrent HER2-positive breast cancer after exposure to adjuvant trastuzumab. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p4-12-20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background:
Trastuzumab has become the cornerstone of adjuvant therapy for patients with HER2-positive breast cancer, as it has significantly impacted on overall survival for these patients. Unfortunately, not all patients are cured, and recurrences occur in up to 13% of patients. In the post-trastuzumab era, long-term outcomes for HER2-positive breast cancer patients who develop recurrent disease after exposure to adjuvant trastuzumab is unknown.
Methods:
We retrospectively identified patients with stage I-III HER2-positive breast cancer treated at The Ohio State University Medical Center from 1995-2011. Patients were divided into two groups: those exposed to adjuvant trastuzumab, and those who never received adjuvant trastuzumab. Medical records were reviewed to obtain demographic data, disease status at diagnosis, adjuvant and metastatic therapeutic regimens, date and location of recurrent disease, date of last follow-up and vital status. Time-dependent analyses were carried out using Kaplan-Meier estimates.
Results:
Six hundred and sixty-two patients were initially identified and included in the analysis. Of the 374 patients who did not receive adjuvant trastuzumab, 96 patients had recurrence (26%). There were 288 patients who received adjuvant trastuzumab, with 33 patients developing relapse (11%). In the patients who received adjuvant trastuzumab and subsequently recurred, there was a higher incidence of CNS recurrence (n = 8; 24%) than those who did not receive adjuvant trastuzumab (n = 10; 10%). Those that received adjuvant trastuzumab also had fewer bone metastases (n = 3; 9%) than the patients who did not receive adjuvant trastuzumab (n = 29; 30%). There was no difference in overall survival in patients with metastatic progression after exposure to adjuvant trastuzumab compared to patients with metastatic HER2-positive breast cancer without prior adjuvant trastuzumab (p = 0.41). Of the 33 patients who relapsed after adjuvant trastuzumab, the majority received HER2-targeted therapy in the form of trastuzumab or lapatinib (n = 22; 67%). Eleven patients received trastuzumab-based therapy and 9 received lapatinib-based therapy. Two patients received the combination of trastuzumab and lapatinib. The remainder received cytotoxic therapy alone (n = 3; 9%), endocrine therapy (n = 1; 3%) or local therapy (surgery or radiation) (n = 4; 12%). Three patients received no therapy.
Conclusion:
There was no difference in overall survival for HER2-positive breast cancer patients who recur after adjuvant trastuzumab compared to metastatic patients without exposure to adjuvant trastuzumab. CNS disease as the first site of recurrence occured more frequently in patients who had received adjuvant trastuzumab than in those who were not previously exposed to trastuzumab. Continued HER2-targeted therapy after relapse on adjuvant trastuzumab was the regimen of choice in the first-line metastatic setting.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P4-12-20.
Collapse
Affiliation(s)
| | | | - J Querry
- The Ohio State University, Columbus, OH
| | - D Akuma
- The Ohio State University, Columbus, OH
| | - A Feng
- The Ohio State University, Columbus, OH
| | | | - E Macrae
- The Ohio State University, Columbus, OH
| |
Collapse
|
18
|
Richmon JD, Chan JY, Feng A. Rapid Discharge after Transoral Robotic Surgery. Otolaryngol Head Neck Surg 2013. [DOI: 10.1177/0194599813495815a125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Objectives: 1) Analyze the Johns Hopkins’ experience of rapid discharge after transoral robotic surgery (TORS). 2) Describe those factors that allow for rapid discharge and those which require longer postoperative hospitalization following TORS. Methods: All transoral robotic surgery (TORS) cases performed by the senior author were retrospectively reviewed. Length of hospitalization (LOH) was the primary outcome measurement. LOH was analyzed in regards to disease process, stage, performance of other concurrent procedures (ie neck dissection, percutaneous endoscopic gastrostomy [PEG] placement), age, gender, co-morbidities, and intra-operative complications. Secondary outcome measures included postoperative complications, tracheotomy and PEG dependency rates, and need for re-admission to hospital. Results: Seventy-eight cases from October 2009 through February 2013 were included for analysis. The average LOH was 1.2 days. LOH was found to be significantly longer in patients with obstructive sleep apnea undergoing lingual tonsillectomy than in oncologic patients. All patients were discharged home on a per oral diet. No patients had a tracheotomy or PEG tube at 6 months postoperatively. The postoperative complication rate was 5% and was independent of the LOH. Conclusions: TORS has seen tremendous growth in the last few years for the treatment of oropharyngeal carcinoma and obstructive sleep apnea (OSA). To date, there have been no formal recommendations regarding postoperative management of these patients. We demonstrate that rapid discharge after undergoing TORS is safe, well-tolerated, has a low complication rate, and does not result in hospital re-admission. However, patients with OSA required longer hospitalizations. This further supports the cost-effectiveness of TORS over other treatment paradigms for oropharyngeal cancer.
Collapse
|
19
|
Geschwind JF, Feng A, Reyes DK, Kamel IR, Gowdra Halappa V, Corona-Villalobos CP, Cosgrove D, Pawlik TM. Prospective phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: Efficacy analysis. J Clin Oncol 2013. [DOI: 10.1200/jco.2013.31.15_suppl.4124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4124 Background: This study reports the final analysis (n=50) of a prospective phase II study evaluating the efficacy of the combination of sorafenib and doxorubicin eluting bead transarterial chemoembolization (DEB-TACE) in patients with unresectable hepatocellular carcinoma (HCC). Methods: Protocol consisted of 6-week cycles with sorafenib at 800 mg/day beginning 1 week prior to DEB-TACE; up to 4 DEB-TACE treatments within 6 months. Tumor response was assessed by RECIST and EASL criteria using MRI at baseline and at 1 month follow-up. Time to untreatable progression (TTUP) was defined as the interval from initiation of sorafenib therapy until inability of patient to further receive intra-arterial therapy. Overall survival (OS) and TTUP were calculated with the Kaplan-Meier method; outcomes were stratified by BCLC A/B and C and compared with the log-rank test. Results: DEB-TACE + sorafenib successfully performed in 50 patients: mean 62yrs (range, 31-88 yrs), Child-Pugh A/B (92%/8%), BCLC A/B/C (10%/28%/62%), ECOG 0/1 (52%/48%), HCV/HBV (44%/8%), mean tumor burden 20%, mean tumor size 7.2cm (range, 1–17.6), and mean tumor enhancement 78%. Patients were enrolled for a median of 3 (range, 1-22) cycles including a median of 1 (range, 0-6) DEB-TACE procedure. Median dose regimen was 400mgQD and the median dose taken while on study was 318 mg/day (range, 100-800). 1 month follow-up showed a mean tumor enhancement reduction of 48.2% (n=46, p<0.001) and an average reduction in lesion diameter of 8.5%(n=48, p=0.02). The Disease Control Rate was 98% using the EASL amendment and RECIST. Median TTUP was 11.9 mths (95% CI, 1.8-22 mths) with a significant difference between BCLC A/B (median 22.9 mths) and BCLC C (median 6.2mths) patients (log-rank, p=0.01). Median OS was 24.5 mths (95% CI, 14.3-35 mths) with a significant difference between BCLC C (median 17.1 mths) and BCLC A/B (median 33.7 mths) patients (log-rank, p=0.001). Conclusions: The results of this phase II study suggest a potential benefit to the combination of sorafenib and DEB-TACE. Single arm and non-randomization are limitations of the study. Clinical trial information: NCT00844883.
Collapse
Affiliation(s)
| | - Allen Feng
- The Johns Hopkins University, School of Medicine, Baltimore, MD
| | - Diane K. Reyes
- The Johns Hopkins University, School of Medicine, Baltimore, MD
| | - Ihab R. Kamel
- The Johns Hopkins University, School of Medicine, Baltimore, MD
| | | | | | - David Cosgrove
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD
| | | |
Collapse
|
20
|
Vadhan-Raj S, von Moos R, Fallowfield LJ, Patrick DL, Goldwasser F, Cleeland CS, Henry DH, Novello S, Hungria V, Qian Y, Feng A, Yeh H, Chung K. Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Ann Oncol 2012; 23:3045-3051. [PMID: 22851406 DOI: 10.1093/annonc/mds175] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/06/2023] Open
Abstract
BACKGROUND Patients with metastatic bone disease are living longer in the metastatic stage due to improvements in cancer therapy, making strategies to prevent the aggravation of bone disease and its complications, such as skeletal-related events (SREs) and pain, increasingly important. PATIENTS AND RESULTS In this phase 3 trial in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma, denosumab reduced the risk of radiation to bone by 22% relative to zoledronic acid (P = 0.026), prevented worsening of pain and pain interference (2-point increase in Brief Pain Inventory score; P < 0.05 versus zoledronic acid), and reduced the frequency of a shift from no/weak opioid analgesic use to strong opioids (P < 0.05 versus zoledronic acid at months 3-5). Denosumab delayed the time to moderate-to-severe pain compared with zoledronic acid in patients with mild or no pain at the baseline (P = 0.04), supporting early treatment. Health-related quality-of-life scores were similar in both groups. The number needed to treat to avoid one SRE for denosumab was 3 patient-years versus placebo and 10 patient-years versus zoledronic acid. CONCLUSION The use of denosumab was associated with better prevention of the complications of metastatic bone disease secondary to solid tumors or multiple myeloma versus zoledronic acid.
Collapse
Affiliation(s)
- S Vadhan-Raj
- Division of Cancer Medicine, Department of Sarcoma Medical Oncology and Lymphoma/Myeloma, Section of Cytokines and Supportive Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
| | - R von Moos
- Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland
| | - L J Fallowfield
- Sussex Health Outcomes Research & Education in Cancer (SHORE-C), University of Sussex, Brighton, UK
| | - D L Patrick
- Department of Health Services, School of Public Health, University of Washington, Seattle, USA
| | - F Goldwasser
- Department of Medical Oncology, Paris Descartes University, AP-HP, Paris, France
| | - C S Cleeland
- Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston
| | - D H Henry
- Department of Hematology-Oncology, Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, USA
| | - S Novello
- Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
| | - V Hungria
- Department of Hematology, Irmandade da Santa Casa de Misericordia de São Paulo, São Paulo, Brazil
| | - Y Qian
- Global Biostatistical Sciences, USA
| | - A Feng
- Global Biostatistical Sciences, USA
| | - H Yeh
- Clinical Development, USA
| | - K Chung
- Global Health Economics, Amgen Inc., Thousand Oaks, USA
| |
Collapse
|
21
|
Shore ND, Smith MR, Jievaltas M, Fizazi K, Damião R, Chin J, Miller K, Maroto JP, Qian Y, Feng A, Chung K, Goessl CD. Effect of denosumab versus zoledronic acid in patients with castrate-resistant prostate cancer and bone metastases: Subgroup analyses by prior SRE and baseline pain. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4533] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
22
|
Brown J, Cleeland C, Fallowfield L, Patrick D, Fizazi K, Smith M, Maroto J, Michel M, Feng A, Goessl C, Chung K. 1091 PAIN OUTCOMES IN PATIENTS WITH BONE METASTASES FROM CASTRATE-RESISTANT PROSTATE CANCER: RESULTS FROM A PHASE 3 TRIAL OF DENOSUMAB VS. ZOLEDRONIC ACID. ACTA ACUST UNITED AC 2011. [DOI: 10.1016/s1569-9056(11)61070-1] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
23
|
Abelev BI, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Anderson BD, Arkhipkin D, Averichev GS, Balewski J, Barannikova O, Barnby LS, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bnzarov I, Bonner BE, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Bruna E, Bueltmann S, Burton TP, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Clarke RF, Codrington MJM, Corliss R, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, De Silva LC, Dedovich TG, DePhillips M, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dzhordzhadze V, Dogra SM, Dong X, Drachenberg JL, Draper JE, Dunlop JC, Dutta Mazumdar MR, Efimov LG, Elhalhuli E, Elnimr M, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Ganti MS, Garcia-Solis EJ, Geromitsos A, Geurts F, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang HZ, Humanic TJ, Huo L, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jena C, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kauder K, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kikola DP, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Konzer J, Kopytine M, Koralt I, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Kravtsov VI, Krueger K, Krus M, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, LeVine MJ, Li C, Li N, Li Y, Lin G, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, Matulenko YA, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Poskanzer AM, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakai S, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Schambach J, Scharenberg RP, Schmitz N, Seele J, Seger J, Selyuzhenkov I, Semertzidis Y, Seyboth P, Shahaliev E, Shao M, Sharma M, Shi SS, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stanislaus TDS, Staszak D, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Tram VN, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbaek F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu Y, Xie W, Xu N, Xu QH, Xu Y, Xu Z, Yang Y, Yepes P, Yip K, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zhu X, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. Azimuthal charged-particle correlations and possible local strong parity violation. Phys Rev Lett 2009; 103:251601. [PMID: 20366248 DOI: 10.1103/physrevlett.103.251601] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/10/2009] [Indexed: 05/29/2023]
Abstract
Parity-odd domains, corresponding to nontrivial topological solutions of the QCD vacuum, might be created during relativistic heavy-ion collisions. These domains are predicted to lead to charge separation of quarks along the system's orbital momentum axis. We investigate a three-particle azimuthal correlator which is a P even observable, but directly sensitive to the charge separation effect. We report measurements of charged hadrons near center-of-mass rapidity with this observable in Au + Au and Cu + Cu collisions at square root of s(NN) = 200 GeV using the STAR detector. A signal consistent with several expectations from the theory is detected. We discuss possible contributions from other effects that are not related to parity violation.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bombara M, Bonner BE, Botje M, Bouchet J, Braidot E, Brandin AV, Bruna E, Bueltmann S, Burton TP, Bystersky M, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Clarke RF, Codrington MJM, Corliss R, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, De Silva LC, Dedovich TG, DePhillips M, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunlop JC, Dutta Mazumdar MR, Edwards WR, Efimov LG, Elhalhuli E, Elnimr M, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gaillard L, Gangadharan DR, Ganti MS, Garcia-Solis EJ, Geromitsos A, Geurts F, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang HZ, Humanic TJ, Huo L, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jena C, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kikola DP, Kiryluk J, Kisiel A, Knospe AG, Kocoloski A, Koetke DD, Kopytine M, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Kravtsov VI, Krueger K, Krus M, Kuhn C, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, Levine MJ, Li N, Li C, Li Y, Lin G, Lindenbaum SJ, Lisa MA, Liu F, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Matis HS, Matulenko YA, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Poskanzer AM, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Raniwala R, Raniwala S, Redwine R, Reed R, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shi SS, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Snellings R, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Tram VN, Trattner AL, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, Vander Molen AM, Vanfossen JA, Varma R, Vasconcelos GMS, Vasilevski IM, Vasiliev AN, Videbaek F, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu Y, Xie W, Xu N, Xu QH, Xu Y, Xu Z, Yang Y, Yepes P, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. Growth of long range forward-backward multiplicity correlations with centrality in Au + Au collisions at square root of sNN = 200 GeV. Phys Rev Lett 2009; 103:172301. [PMID: 19905749 DOI: 10.1103/physrevlett.103.172301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/02/2009] [Indexed: 05/28/2023]
Abstract
Forward-backward multiplicity correlation strengths have been measured with the STAR detector for Au + Au and p + p collisions at square root of s(NN) = 200 GeV. Strong short- and long-range correlations (LRC) are seen in central Au + Au collisions. The magnitude of these correlations decrease with decreasing centrality until only short-range correlations are observed in peripheral Au + Au collisions. Both the dual parton model (DPM) and the color glass condensate (CGC) predict the existence of the long-range correlations. In the DPM, the fluctuation in the number of elementary (parton) inelastic collisions produces the LRC. In the CGC, longitudinal color flux tubes generate the LRC. The data are in qualitative agreement with the predictions of the DPM and indicate the presence of multiple parton interactions.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bombara M, Bonner BE, Botje M, Bouchet J, Braidot E, Brandin AV, Bruna E, Bueltmann S, Burton TP, Bystersky M, Cai XZ, Caines H, de la Barca Sánchez MC, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Clarke RF, Codrington MJM, Corliss R, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Das S, Dash S, Daugherity M, De Silva LC, Dedovich TG, DePhillips M, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Dunlop JC, Mazumdar MRD, Edwards WR, Efimov LG, Elhalhuli E, Elnimr M, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gaillard L, Gangadharan DR, Ganti MS, Garcia-Solis EJ, Geromitsos A, Geurts F, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang HZ, Humanic TJ, Huo L, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jena C, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kikola DP, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kopytine M, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Kravtsov VI, Krueger K, Krus M, Kuhn C, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, LeVine MJ, Li C, Li N, Li Y, Lin G, Lindenbaum SJ, Lisa MA, Liu F, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Matis HS, Matulenko YA, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Poskanzer AM, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Raniwala R, Raniwala S, Redwine R, Reed R, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shi SS, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Snellings R, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Symons TJM, de Toledo AS, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Tram VN, Trattner AL, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, Molen AMV, Vanfossen JA, Varma R, Vasconcelos GMS, Vasilevski IM, Vasiliev AN, Videbaek F, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu Y, Xie W, Xu N, Xu QH, Xu Y, Xu Z, Yang P, Yepes P, Yip K, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. K/pi Fluctuations at relativistic energies. Phys Rev Lett 2009; 103:092301. [PMID: 19792791 DOI: 10.1103/physrevlett.103.092301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/12/2009] [Indexed: 05/28/2023]
Abstract
We report K/pi fluctuations from Au + Au collisions at sqrt[s(NN)]= 19.6, 62.4, 130, and 200 GeV using the STAR detector at the Relativistic Heavy Ion Collider. K/pi fluctuations in central collisions show little dependence on incident energy and are on the same order as those from NA49 at the Super Proton Synchrotron in central Pb + Pb collisions at sqrt[s(NN)]=12.3 and 17.3 GeV. We report results for the collision centrality dependence of K/pi fluctuations and results for charge-separated fluctuations. We observe that the K/pi fluctuations scale with the charged particle multiplicity density.
Collapse
Affiliation(s)
- B I Abelev
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bombara M, Bonner BE, Botje M, Bouchet J, Braidot E, Brandin AV, Bruna E, Bueltmann S, Burton TP, Bystersky M, Cai XZ, Caines H, Sánchez MCDLB, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Clarke RF, Codrington MJM, Corliss R, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, Silva LCD, Dedovich TG, DePhillips M, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunlop JC, Mazumdar MRD, Edwards WR, Efimov LG, Elhalhuli E, Elnimr M, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gaillard L, Gangadharan DR, Ganti MS, Garcia-Solis EJ, Geromitsos A, Geurts F, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang HZ, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jena C, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kikola DP, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kopytine M, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Kravtsov VI, Krueger K, Krus M, Kuhn C, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, LeVine MJ, Li N, Li C, Li Y, Lin G, Lindenbaum SJ, Lisa MA, Liu F, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Matis HS, Matulenko YA, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Poskanzer AM, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Putschke J, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shi SS, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Snellings R, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Symons TJM, de Toledo AS, Takahashi J, Tang AH, Tang Z, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Trainor TA, Tram VN, Trattner AL, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, Molen AMV, Vanfossen JA, Varma R, Vasconcelos GMS, Vasilevski IM, Vasiliev AN, Videbaek F, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Waggoner WT, Walker M, Wang F, Wang G, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu Y, Xie W, Xu N, Xu QH, Xu Y, Xu Z, Yang Y, Yepes P, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. Measurement ofD*mesons in jets fromp+pcollisions ats=200 GeV. Int J Clin Exp Med 2009. [DOI: 10.1103/physrevd.79.112006] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
27
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betancourt MJ, Betts RR, Bhardwaj S, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bombara M, Bonner BE, Botje M, Bouchet J, Braidot E, Brandin AV, Bruna E, Bueltmann S, Burton TP, Bystersky M, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Callner J, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung SU, Clarke RF, Codrington MJM, Coffin JP, Corliss R, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, De Silva C, Dedovich TG, Dephillips M, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunlop JC, Dutta Mazumdar MR, Edwards WR, Efimov LG, Elhalhuli E, Elnimr M, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gaillard L, Gangadharan DR, Ganti MS, Garcia-Solis E, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang HZ, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jin F, Jones CL, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kaplan M, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kikola DP, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kopytine M, Kotchenda L, Kouchpil V, Kravtsov P, Kravtsov VI, Krueger K, Krus M, Kuhn C, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, Lapointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Leight W, Levine MJ, Li C, Li N, Li Y, Lin G, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Matis HS, Matulenko YA, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Nepali C, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Poskanzer AM, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Putschke J, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Rykov V, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shi SS, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Snellings R, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Trainor TA, Tram VN, Trattner AL, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, Vander Molen AM, Vanfossen JA, Varma R, Vasconcelos GMS, Vasilevski IM, Vasiliev AN, Videbaek F, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Waggoner WT, Walker M, Wang F, Wang G, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu Y, Xie W, Xu N, Xu QH, Xu Y, Xu Z, Yepes P, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang H, Zhang S, Zhang WM, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. Observation of two-source interference in the photoproduction reaction AuAu --> AuAurho0. Phys Rev Lett 2009; 102:112301. [PMID: 19392193 DOI: 10.1103/physrevlett.102.112301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2008] [Indexed: 05/27/2023]
Abstract
In ultraperipheral relativistic heavy-ion collisions, a photon from the electromagnetic field of one nucleus can fluctuate to a quark-antiquark pair and scatter from the other nucleus, emerging as a rho{0}. The rho{0} production occurs in two well-separated (median impact parameters of 20 and 40 F for the cases considered here) nuclei, so the system forms a two-source interferometer. At low transverse momenta, the two amplitudes interfere destructively, suppressing rho{0} production. Since the rho{0} decays before the production amplitudes from the two sources can overlap, the two-pion system can only be described with an entangled nonlocal wave function, and is thus an example of the Einstein-Podolsky-Rosen paradox. We observe this suppression in 200 GeV per nucleon-pair gold-gold collisions. The interference is 87%+/-5%(stat.)+/-8%(syst.) of the expected level. This translates into a limit on decoherence due to wave function collapse or other factors of 23% at the 90% confidence level.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betts RR, Bhardwaj S, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bombara M, Bonner BE, Botje M, Bouchet J, Braidot E, Brandin AV, Bruna E, Bueltmann S, Burton TP, Bystersky M, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Callner J, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung SU, Clarke RF, Codrington MJM, Coffin JP, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, De Silva C, de Moura MM, Dedovich TG, Dephillips M, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunlop JC, Dutta Mazumdar MR, Edwards WR, Efimov LG, Elhalhuli E, Elnimr M, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gaillard L, Gangadharan DR, Ganti MS, Garcia-Solis E, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang HZ, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jin F, Jones PG, Joseph J, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kaplan M, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kopytine M, Kotchenda L, Kouchpil V, Kravtsov P, Kravtsov VI, Krueger K, Krus M, Kuhn C, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, Lapointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Levine MJ, Li C, Li Y, Lin G, Lin X, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Matis HS, Matulenko YA, McShane TS, Meschanin A, Millane J, Miller ML, Minaev NG, Mioduszewski S, Mischke A, Mitchell J, Mohanty B, Molnar L, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Nepali C, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Poskanzer AM, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Putschke J, Raniwala R, Raniwala S, Ray RL, Reed R, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Rykov V, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shi SS, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Snellings R, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Trainor TA, Tram VN, Trattner AL, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, Vander Molen AM, Vanfossen JA, Varma R, Vasconcelos GMS, Vasilevski IM, Vasiliev AN, Videbaek F, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Waggoner WT, Wang F, Wang G, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu Y, Xu N, Xu QH, Xu Y, Xu Z, Yepes P, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang H, Zhang S, Zhang WM, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. Indications of conical emission of charged hadrons at the BNL relativistic heavy ion collider. Phys Rev Lett 2009; 102:052302. [PMID: 19257508 DOI: 10.1103/physrevlett.102.052302] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2008] [Indexed: 05/27/2023]
Abstract
Three-particle azimuthal correlation measurements with a high transverse momentum trigger particle are reported for pp, d+Au, and Au+Au collisions at sqrt[s_{NN}]=200 GeV by the STAR experiment. Dijet structures are observed in pp, d+Au and peripheral Au+Au collisions. An additional structure is observed in central Au+Au data, signaling conical emission of correlated charged hadrons. The conical emission angle is found to be theta=1.37+/-0.02(stat)-0.07+0.06(syst), independent of p_{ perpendicular}.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betts RR, Bhardwaj S, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Bombara M, Bonner BE, Botje M, Bouchet J, Braidot E, Brandin AV, Bueltmann S, Burton TP, Bystersky M, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Callner J, Catu O, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung SU, Clarke RF, Codrington MJM, Coffin JP, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, de Moura MM, Dedovich TG, Dephillips M, Derevschikov AA, Derradi de Souza R, Didenko L, Dietel T, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunlop JC, Dutta Mazumdar MR, Edwards WR, Efimov LG, Elhalhuli E, Elnimr M, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gaillard L, Gangadharan DR, Ganti MS, Garcia-Solis E, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Heppelmann S, Hippolyte B, Hirsch A, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Huang HZ, Hughes EW, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jin F, Jones PG, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kaplan M, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kouchpil V, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kumar A, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, Lange S, Lapointe S, Laue F, Lauret J, Lebedev A, Lednicky R, Lee CH, Levine MJ, Li C, Li Y, Lin G, Lin X, Lindenbaum SJ, Lisa MA, Liu F, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma JG, Ma YG, Mahapatra DP, Majka R, Mangotra LK, Manweiler R, Margetis S, Markert C, Matis HS, Matulenko YA, McShane TS, Meschanin A, Millane J, Miller ML, Minaev NG, Mioduszewski S, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Nepali C, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Pal SK, Panebratsev Y, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Porile N, Poskanzer AM, Potekhin M, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Putschke J, Qattan IA, Raniwala R, Raniwala S, Ray RL, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Rykov V, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shi SS, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Snellings R, Sorensen P, Sowinski J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tokarev M, Trainor TA, Tram VN, Trattner AL, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van der Kolk N, van Leeuwen M, Vander Molen AM, Varma R, Vasconcelos GMS, Vasilevski IM, Vasiliev AN, Videbaek F, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Waggoner WT, Wang F, Wang G, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu J, Wu Y, Xu N, Xu QH, Xu Y, Xu Z, Yang YY, Yepes P, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang H, Zhang S, Zhang WM, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. System-size independence of directed flow measured at the BNL relativistic heavy-ion collider. Phys Rev Lett 2008; 101:252301. [PMID: 19113699 DOI: 10.1103/physrevlett.101.252301] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/10/2008] [Indexed: 05/27/2023]
Abstract
We measure directed flow (v_{1}) for charged particles in Au+Au and Cu+Cu collisions at sqrt[s_{NN}]=200 and 62.4 GeV, as a function of pseudorapidity (eta), transverse momentum (p_{t}), and collision centrality, based on data from the STAR experiment. We find that the directed flow depends on the incident energy but, contrary to all available model implementations, not on the size of the colliding system at a given centrality. We extend the validity of the limiting fragmentation concept to v_{1} in different collision systems, and investigate possible explanations for the observed sign change in v_{1}(p_{t}).
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Beavis DR, Bellwied R, Benedosso F, Betts RR, Bhardwaj S, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Blyth SL, Bombara M, Bonner BE, Botje M, Bouchet J, Braidot E, Brandin AV, Bueltmann S, Burton TP, Bystersky M, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Callner J, Catu O, Cebra D, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung SU, Clarke RF, Codrington MJM, Coffin JP, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, de Moura MM, Dedovich TG, DePhillips M, Derevschikov AA, Derradi de Souza R, Didenko L, Dietel T, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunlop JC, Dutta Mazumdar MR, Edwards WR, Efimov LG, Elhalhuli E, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Fu J, Gagliardi CA, Gaillard L, Ganti MS, Garcia-Solis E, Ghazikhanian V, Ghosh P, Gorbunov YN, Gordon A, Gos H, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Guryn W, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Henry TW, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Horner MJ, Huang HZ, Hughes EW, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jin F, Jones PG, Judd EG, Kabana S, Kajimoto K, Kang K, Kapitan J, Kaplan M, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kiryluk J, Kisiel A, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kouchpil V, Kowalik KL, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kumar A, Kurnadi P, Lamont MAC, Landgraf JM, Langdon J, Lange S, LaPointe S, Laue F, Lauret J, Lebedev A, Lednicky R, Lee CH, LeVine MJ, Li C, Li Q, Li Y, Lin G, Lin X, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma JG, Ma YG, Mahapatra DP, Majka R, Mangotra LK, Manweiler R, Margetis S, Markert C, Matis HS, Matulenko YA, McShane TS, Meschanin A, Millane J, Miller C, Miller ML, Minaev NG, Mioduszewski S, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Nepali C, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okada H, Okorokov V, Olson D, Pachr M, Pal SK, Panebratsev Y, Pavlinov AI, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Porile N, Poskanzer AM, Potekhin M, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Putschke J, Qattan IA, Rakness G, Raniwala R, Raniwala S, Ray RL, Relyea D, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Rykov V, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shi XH, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Snellings R, Sorensen P, Sowinski J, Speltz J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarnowsky T, Tatarowicz J, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tokarev M, Trainor TA, Tram VN, Trattner AL, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van der Kolk N, van Leeuwen M, Vander Molen AM, Varma R, Vasconcelos GMS, Vasilevski IM, Vasiliev AN, Vernet R, Videbaek F, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Waggoner WT, Wang F, Wang G, Wang JS, Wang Q, Wang X, Wang XL, Wang Y, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu J, Wu Y, Xu N, Xu QH, Xu Z, Yepes P, Yoo IK, Yue Q, Zachariou N, Zawisza M, Zhan W, Zhang H, Zhang S, Zhang WM, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zuo JX. Forward neutral-pion transverse single-spin asymmetries in p + p collisions at sqrt[s] = 200 GeV. Phys Rev Lett 2008; 101:222001. [PMID: 19113478 DOI: 10.1103/physrevlett.101.222001] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2008] [Indexed: 05/27/2023]
Abstract
We report precision measurements of the Feynman x (xF) dependence, and first measurements of the transverse momentum (pT) dependence, of transverse single-spin asymmetries for the production of pi0 mesons from polarized proton collisions at sqrt[s] = 200 GeV. The xF dependence of the results is in fair agreement with perturbative QCD model calculations that identify orbital motion of quarks and gluons within the proton as the origin of the spin effects. Results for the pT dependence at fixed xF are not consistent with these same perturbative QCD-based calculations.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Belaga VV, Bellingeri-Laurikainen A, Bellwied R, Benedosso F, Betts RR, Bhardwaj S, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Blyth SL, Bombara M, Bonner BE, Botje M, Bouchet J, Brandin AV, Burton TP, Bystersky M, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Callner J, Catu O, Cebra D, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Christie W, Chung SU, Clarke RF, Codrington MJM, Coffin JP, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, de Moura MM, Dedovich TG, Dephillips M, Derevschikov AA, Didenko L, Dietel T, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunin VB, Dunlop JC, Dutta Mazumdar MR, Edwards WR, Efimov LG, Elhalhuli E, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Fu J, Gagliardi CA, Gaillard L, Ganti MS, Garcia-Solis E, Ghazikhanian V, Ghosh P, Gorbunov YN, Gos H, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Henry TW, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Horner MJ, Huang HZ, Hughes EW, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jones PG, Judd EG, Kabana S, Kang K, Kapitan J, Kaplan M, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kiryluk J, Kisiel A, Kislov EM, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kouchpil V, Kowalik KL, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kurnadi P, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lapointe S, Laue F, Lauret J, Lebedev A, Lednicky R, Lee CH, Lehocka S, Levine MJ, Li C, Li Q, Li Y, Lin G, Lin X, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma JG, Ma YG, Mahapatra DP, Majka R, Mangotra LK, Manweiler R, Margetis S, Markert C, Martin L, Matis HS, Matulenko YA, McShane TS, Meschanin A, Millane J, Miller ML, Minaev NG, Mioduszewski S, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Nepali C, Netrakanti PK, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Olson D, Pachr M, Pal SK, Panebratsev Y, Pavlinov AI, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Porile N, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Putschke J, Qattan IA, Raniwala R, Raniwala S, Ray RL, Relyea D, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Sazhin PS, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shen WQ, Shimanskiy SS, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Snellings R, Sorensen P, Sowinski J, Speltz J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tarnowsky T, Thomas JH, Timmins AR, Timoshenko S, Tokarev M, Trainor TA, Tram VN, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van der Kolk N, van Leeuwen M, Vander Molen AM, Varma R, Vasilevski IM, Vasiliev AN, Vernet R, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Waggoner WT, Wang F, Wang G, Wang JS, Wang XL, Wang Y, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu J, Wu Y, Xu N, Xu QH, Xu Z, Yepes P, Yoo IK, Yue Q, Yurevich VI, Zawisza M, Zhan W, Zhang H, Zhang WM, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zubarev AN, Zuo JX. Longitudinal double-spin asymmetry for inclusive jet production in p[over -->] + p[over -->] collisions at sqrt[s]=200 GeV. Phys Rev Lett 2008; 100:232003. [PMID: 18643488 DOI: 10.1103/physrevlett.100.232003] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2007] [Indexed: 05/26/2023]
Abstract
We report a new STAR measurement of the longitudinal double-spin asymmetry A(LL) for inclusive jet production at midrapidity in polarized p + p collisions at a center-of-mass energy of sqrt[s]=200 GeV. The data, which cover jet transverse momenta 5<p(T)<30 GeV/c, are substantially more precise than previous measurements. They provide significant new constraints on the gluon spin contribution to the nucleon spin through the comparison to predictions derived from one global fit to polarized deep-inelastic scattering measurements.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, IL 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Belaga VV, Bellingeri-Laurikainen A, Bellwied R, Benedosso F, Betts RR, Bhardwaj S, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Blyth SL, Bombara M, Bonner BE, Botje M, Bouchet J, Brandin AV, Burton TP, Bystersky M, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Callner J, Catu O, Cebra D, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Christie W, Chung SU, Clarke RF, Codrington MJM, Coffin JP, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, de Moura MM, Dedovich TG, Dephillips M, Derevschikov AA, Didenko L, Dietel T, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunin VB, Dunlop JC, Dutta Mazumdar MR, Edwards WR, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Fu J, Gagliardi CA, Gaillard L, Ganti MS, Garcia-Solis E, Ghazikhanian V, Ghosh P, Gorbunov YN, Gos H, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta A, Gupta N, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Henry TW, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Horner MJ, Huang HZ, Hughes EW, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jones PG, Judd EG, Kabana S, Kang K, Kapitan J, Kaplan M, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kiryluk J, Kisiel A, Kislov EM, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kouchpil V, Kowalik KL, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kurnadi P, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lapointe S, Laue F, Lauret J, Lebedev A, Lednicky R, Lee CH, Lehocka S, Levine MJ, Li C, Li Q, Li Y, Lin G, Lin X, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma JG, Ma YG, Mahapatra DP, Majka R, Mangotra LK, Manweiler R, Margetis S, Markert C, Martin L, Matis HS, Matulenko YA, McShane TS, Meschanin A, Millane J, Miller ML, Minaev NG, Mioduszewski S, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Nepali C, Netrakanti PK, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Olson D, Pachr M, Pal SK, Panebratsev Y, Pavlinov AI, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Porile N, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Pruthi NK, Putschke J, Qattan IA, Raniwala R, Raniwala S, Ray RL, Relyea D, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Sazhin PS, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shen WQ, Shimanskiy SS, Sichtermann EP, Simon F, Singaraju RN, Smirnov N, Snellings R, Sorensen P, Sowinski J, Speltz J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Stevens J, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tarnowsky T, Thomas JH, Timmins AR, Timoshenko S, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van der Kolk N, van Leeuwen M, Vander Molen AM, Varma R, Vasilevski IM, Vasiliev AN, Vernet R, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Wada M, Waggoner WT, Wang F, Wang G, Wang JS, Wang XL, Wang Y, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu J, Wu Y, Xu N, Xu QH, Xu Z, Yepes P, Yoo IK, Yue Q, Yurevich VI, Zawisza M, Zhan W, Zhang H, Zhang WM, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zubarev AN, Zuo JX. Measurement of transverse single-spin asymmetries for Dijet production in proton-proton collisions at sqrt[s]=200 GeV. Phys Rev Lett 2007; 99:142003. [PMID: 17930662 DOI: 10.1103/physrevlett.99.142003] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2007] [Indexed: 05/25/2023]
Abstract
We report the first measurement of the opening angle distribution between pairs of jets produced in high-energy collisions of transversely polarized protons. The measurement probes (Sivers) correlations between the transverse spin orientation of a proton and the transverse momentum directions of its partons. With both beams polarized, the wide pseudorapidity (-1< or = eta < or = +2) coverage for jets permits separation of Sivers functions for the valence and sea regions. The resulting asymmetries are all consistent with zero and considerably smaller than Sivers effects observed in semi-inclusive deep inelastic scattering. We discuss theoretical attempts to reconcile the new results with the sizable transverse spin effects seen in semi-inclusive deep inelastic scattering and forward hadron production in pp collisions.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, IL 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Belaga VV, Bellingeri-Laurikainen A, Bellwied R, Benedosso F, Betts RR, Bhardwaj S, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Blyth SL, Bombara M, Bonner BE, Botje M, Bouchet J, Brandin AV, Bravar A, Burton TP, Bystersky M, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Callner J, Catu O, Cebra D, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Christie W, Chung SU, Coffin JP, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, de Moura MM, Dedovich TG, DePhillips M, Derevschikov AA, Didenko L, Dietel T, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunin VB, Dunlop JC, Dutta Mazumdar MR, Eckardt V, Edwards WR, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Fu J, Gagliardi CA, Gaillard L, Ganti MS, Garcia-Solis E, Ghazikhanian V, Ghosh P, Gorbunov YG, Gos H, Grebenyuk O, Grosnick D, Grube B, Guertin SM, Guimaraes KSFF, Gupta N, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Henry TW, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman DJ, Hollis RS, Horner MJ, Huang HZ, Hughes EW, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jia F, Jones PG, Judd EG, Kabana S, Kang K, Kapitan J, Kaplan M, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kim BC, Kiryluk J, Kisiel A, Kislov EM, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kouchpil V, Kowalik KL, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kurnadi P, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, LaPointe S, Laue F, Lauret J, Lebedev A, Lednicky R, Lee CH, Lehocka S, LeVine MJ, Li C, Li Q, Li Y, Lin G, Lin X, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma JG, Ma YG, Mahapatra DP, Majka R, Mangotra LK, Manweiler R, Margetis S, Markert C, Martin L, Matis HS, Matulenko YA, McClain CJ, McShane TS, Melnick Y, Meschanin A, Millane J, Miller ML, Minaev NG, Mioduszewski S, Mironov C, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Nepali C, Netrakanti PK, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Pachr M, Pal SK, Panebratsev Y, Pavlinov AI, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Porile N, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Qattan IA, Raniwala R, Raniwala S, Ray RL, Relyea D, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Sazhin PS, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shen WQ, Shimanskiy SS, Sichtermann EP, Simon F, Singaraju RN, Smirnov N, Snellings R, Sorensen P, Sowinski J, Speltz J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tarnowsky T, Thomas JH, Timmins AR, Timoshenko S, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van der Kolk N, van Leeuwen M, Vander Molen AM, Varma R, Vasilevski IM, Vasiliev AN, Vernet R, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Waggoner WT, Wang F, Wang G, Wang JS, Wang XL, Wang Y, Watson JW, Webb JC, Westfall GD, Wetzler A, Whitten C, Wieman H, Wissink SW, Witt R, Wu J, Wu Y, Xu N, Xu QH, Xu Z, Yepes P, Yoo IK, Yue Q, Yurevich VI, Zhan W, Zhang H, Zhang WM, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zubarev AN, Zuo JX. Partonic Flow and phi-Meson production in Au+Au collisions at sqrt radical sNN = 200 GeV. Phys Rev Lett 2007; 99:112301. [PMID: 17930430 DOI: 10.1103/physrevlett.99.112301] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/20/2007] [Indexed: 05/25/2023]
Abstract
We present first measurements of the phi-meson elliptic flow (v2(pT)) and high-statistics pT distributions for different centralities from radical sNN=200 GeV Au+Au collisions at RHIC. In minimum bias collisions the v2 of the phi meson is consistent with the trend observed for mesons. The ratio of the yields of the Omega to those of the phi as a function of transverse momentum is consistent with a model based on the recombination of thermal s quarks up to pT approximately 4 GeV/c, but disagrees at higher momenta. The nuclear modification factor (R CP) of phi follows the trend observed in the K S 0 mesons rather than in Lambda baryons, supporting baryon-meson scaling. These data are consistent with phi mesons in central Au+Au collisions being created via coalescence of thermalized s quarks and the formation of a hot and dense matter with partonic collectivity at RHIC.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Abelev BI, Aggarwal MM, Ahammed Z, Anderson BD, Arkhipkin D, Averichev GS, Bai Y, Balewski J, Barannikova O, Barnby LS, Baudot J, Baumgart S, Belaga VV, Bellingeri-Laurikainen A, Bellwied R, Benedosso F, Betts RR, Bhardwaj S, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Blyth SL, Bombara M, Bonner BE, Botje M, Bouchet J, Brandin AV, Bravar A, Burton TP, Bystersky M, Cadman RV, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Callner J, Catu O, Cebra D, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Christie W, Chung SU, Coffin JP, Cormier TM, Cosentino MR, Cramer JG, Crawford HJ, Das D, Dash S, Daugherity M, de Moura MM, Dedovich TG, Dephillips M, Derevschikov AA, Didenko L, Dietel T, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du F, Dunin VB, Dunlop JC, Dutta Mazumdar MR, Eckardt V, Edwards WR, Efimov LG, Emelianov V, Engelage J, Eppley G, Erazmus B, Estienne M, Fachini P, Fatemi R, Fedorisin J, Feng A, Filip P, Finch E, Fine V, Fisyak Y, Fu J, Gagliardi CA, Gaillard L, Ganti MS, Garcia-Solis E, Ghazikhanian V, Ghosh P, Gorbunov YG, Gos H, Grebenyuk O, Grosnick D, Guertin SM, Guimaraes KSFF, Gupta N, Haag B, Hallman TJ, Hamed A, Harris JW, He W, Heinz M, Henry TW, Heppelmann S, Hippolyte B, Hirsch A, Hjort E, Hoffman AM, Hoffmann GW, Hofman D, Hollis R, Horner MJ, Huang HZ, Hughes EW, Humanic TJ, Igo G, Iordanova A, Jacobs P, Jacobs WW, Jakl P, Jia F, Jones PG, Judd EG, Kabana S, Kang K, Kapitan J, Kaplan M, Keane D, Kechechyan A, Kettler D, Khodyrev VY, Kim BC, Kiryluk J, Kisiel A, Kislov EM, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Kopytine M, Kotchenda L, Kouchpil V, Kowalik KL, Kravtsov P, Kravtsov VI, Krueger K, Kuhn C, Kulikov AI, Kumar A, Kurnadi P, Kuznetsov AA, Lamont MAC, Landgraf JM, Lange S, Lapointe S, Laue F, Lauret J, Lebedev A, Lednicky R, Lee CH, Lehocka S, LeVine MJ, Li C, Li Q, Li Y, Lin G, Lin X, Lindenbaum SJ, Lisa MA, Liu F, Liu H, Liu J, Liu L, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Ludlam T, Lynn D, Ma GL, Ma JG, Ma YG, Magestro D, Mahapatra DP, Majka R, Mangotra LK, Manweiler R, Margetis S, Markert C, Martin L, Matis HS, Matulenko YA, McClain CJ, McShane TS, Melnick Y, Meschanin A, Millane J, Miller ML, Minaev NG, Mioduszewski S, Mironov C, Mischke A, Mitchell J, Mohanty B, Morozov DA, Munhoz MG, Nandi BK, Nattrass C, Nayak TK, Nelson JM, Nepali NS, Netrakanti PK, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Okorokov V, Oldenburg M, Olson D, Pachr M, Pal SK, Panebratsev Y, Pavlinov AI, Pawlak T, Peitzmann T, Perevoztchikov V, Perkins C, Peryt W, Phatak SC, Planinic M, Pluta J, Poljak N, Porile N, Poskanzer AM, Potekhin M, Potrebenikova E, Potukuchi BVKS, Prindle D, Pruneau C, Putschke J, Qattan IA, Raniwala R, Raniwala S, Ray RL, Relyea D, Ridiger A, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Roy C, Ruan L, Russcher MJ, Sahoo R, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sarsour M, Sazhin PS, Schambach J, Scharenberg RP, Schmitz N, Seger J, Selyuzhenkov I, Seyboth P, Shabetai A, Shahaliev E, Shao M, Sharma M, Shen WQ, Shimanskiy SS, Sichtermann EP, Simon F, Singaraju RN, Smirnov N, Snellings R, Sorensen P, Sowinski J, Speltz J, Spinka HM, Srivastava B, Stadnik A, Stanislaus TDS, Staszak D, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Z, Surrow B, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tarnowsky T, Thomas JH, Timmins AR, Timoshenko S, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tsai OD, Ulery J, Ullrich T, Underwood DG, Van Buren G, van der Kolk N, van Leeuwen M, Vander Molen AM, Varma R, Vasilevski IM, Vasiliev AN, Vernet R, Vigdor SE, Viyogi YP, Vokal S, Voloshin SA, Waggoner WT, Wang F, Wang G, Wang JS, Wang XL, Wang Y, Watson JW, Webb JC, Westfall GD, Wetzler A, Whitten C, Wieman H, Wissink SW, Witt R, Wu J, Wu Y, Xu N, Xu QH, Xu Z, Yepes P, Yoo IK, Yue Q, Yurevich VI, Zhan W, Zhang H, Zhang WM, Zhang Y, Zhang ZP, Zhao Y, Zhong C, Zhou J, Zoulkarneev R, Zoulkarneeva Y, Zubarev AN, Zuo JX. Transverse momentum and centrality dependence of high-pT nonphotonic electron suppression in Au+Au collisions at sqrt[s NN]=200 GeV. Phys Rev Lett 2007; 98:192301. [PMID: 17677616 DOI: 10.1103/physrevlett.98.192301] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/11/2006] [Revised: 01/15/2007] [Indexed: 05/16/2023]
Abstract
The STAR collaboration at the BNL Relativistic Heavy-Ion Collider (RHIC) reports measurements of the inclusive yield of nonphotonic electrons, which arise dominantly from semileptonic decays of heavy flavor mesons, over a broad range of transverse momenta (1.2<p(T)<10 GeV/c) in p+p, d+Au, and Au+Au collisions at sqrt[s_{NN}]=200 GeV. The nonphotonic electron yield exhibits an unexpectedly large suppression in central Au+Au collisions at high p(T), suggesting substantial heavy-quark energy loss at RHIC. The centrality and p(T) dependences of the suppression provide constraints on theoretical models of suppression.
Collapse
Affiliation(s)
- B I Abelev
- University of Illinois, Chicago, IL 61801, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Cheng S, Yen K, Jian J, Tsai S, Feng A, Chu N, Lin Y, Chan K, Lin C, Tan T, Hsieh C, Huang A. The potential routes of distant metastasis for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003. [DOI: 10.1016/s0360-3016(03)01349-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
36
|
Al-Gazali LI, Ravenscroft A, Feng A, Shubbar A, Al-Saggaf A, Haas D. Stüve-Wiedemann syndrome in children surviving infancy: clinical and radiological features. Clin Dysmorphol 2003; 12:1-8. [PMID: 12514358 DOI: 10.1097/00019605-200301000-00001] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
We report three children from two inbred Arab families with Stüve-Wiedemann syndrome who have survived the first year of life (ages are 6 years, 2.8 years and 2 years). All exhibited a characteristic phenotype resembling that described by Chen et al.[(2001). Am J Med Genet 101:240-245]. In all three children the skeletal abnormalities progressed to severe bowing of the long bones with prominent joints and severe spinal deformity. Neurological symptoms were present in all of them. These included temperature instability with excessive sweating, reduced pain sensation with repeated injury to the tongue and limbs, absent corneal reflexes and a smooth tongue. Mentality was normal in all of them. Radiological changes included under tubulation of the diaphyses, rarefaction and striation of metaphyses, destruction of the femoral heads and spinal deformity. We confirm that survival in this syndrome is possible and that the prognosis improves after the first year of life. This should be taken into consideration when counselling parents of affected children. This report further supports the existence of a characteristic phenotype in Stüve-Wiedemann syndrome survivors which include, in addition to the skeletal abnormalities and distinctive radiological features, neurological symptoms reminiscent of dysautonomia.
Collapse
Affiliation(s)
- L I Al-Gazali
- Paediatrics Department, Faculty of Medicine and Health Sciences, UAE University, PO Box 17666, Al Ain, United Arab Emirates.
| | | | | | | | | | | |
Collapse
|
37
|
Abstract
BACKGROUND The existence of an effective antitumour immune response in mycosis fungoides (MF) has been shown by the isolation of tumour-specific T-cell clones from such patients. Dendritic cells (DCs) are considered crucial for the induction of immunity, including resistance to tumours. Apoptotic tumour cells are a major source for tumour antigens processed and presented by DCs via cross-presentation. The production of interleukin (IL)-10 by MF tumour cells is acknowledged and may block DCs maturation leading to tumour tolerance. OBJECTIVES Cross-presentation of apoptotic tumour cells by DCs will induce immunity if the DCs mature, but tolerance if maturation does not occur. We now further characterize the DCs in skin infiltrates of patch/plaque-stage MF (PS) and tumour-stage MF (TS) in situ. Secondly, we demonstrate apoptosis in MF infiltrates in situ and analyse the association of apoptotic cells to immature DCs, mature DCs and IL-10-positive cells. METHODS Immunohistochemical staining (single, double, triple) employing novel markers specific for immature and mature DCs, IL-10 and a terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labelling (TUNEL) test were done on representative skin biopsies from PS and TS. RESULTS In PS, the immature DCs are mostly lag/langerin + Langerhans cells (LCs). In the epidermis of PS, LCs predominate over fully mature DCs (non-LC type, CD83+, DC-lamp+). In the dermis of PS and TS, equal numbers of mature and immature (CD1a+, CD1c+) DCs are densely interspersed between the lymphocytic infiltrate. In TS, immature DCs mostly lack lag or langerin expression. Immature DCs with incorporated apoptotic cells were found rarely in PS but increasingly in TS. By triple staining in situ we could now show that strongly IL-10+ cells frequently surround immature DCs, some of them with incorporated apoptotic cells. CONCLUSIONS; DCs in MF perform a dual role, namely induction and maintenance of antitumour immunity, or, under less favourable circumstances such as production of IL-10 downregulation of antitumour immunity. The latter condition was mainly seen in TS, possibly explaining disease progression. Further in vitro studies are now required illuminating the role of DCs for the antitumour immune response in MF.
Collapse
Affiliation(s)
- M Lüftl
- Department of Dermatology, University Hospital of Erlangen, Hartmannstr. 14, D-91052 Erlangen, Germany.
| | | | | | | |
Collapse
|
38
|
Oefelein MG, Feng A, Scolieri MJ, Ricchiutti D, Resnick MI. Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making. Urology 2000; 56:1021-4. [PMID: 11113751 DOI: 10.1016/s0090-4295(00)00793-7] [Citation(s) in RCA: 197] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
OBJECTIVES Based on methods introduced in the late 1960s and no longer used, serum testosterone level in men after surgical castration was reported to be 50 ng/dL or less. Radioimmunoassay and, subsequently, chemiluminescent methods have supplanted the early analytic methods because of their improved accuracy and ease of testing. The purpose of this study was to define the castrate testosterone level in the era of chemiluminescent testing. METHODS After bilateral orchiectomy, serum testosterone (total) levels were measured prospectively in 35 prostate cancer patients. RESULTS The median testosterone value in this patient cohort was 15 ng/dL (0.5 nmol/L; 95% confidence interval 12 to 17 ng/dL). CONCLUSIONS In a contemporary series, castrate testosterone should be defined as less than 20 ng/dL (0.7 nmol/L). The important biologic and economic implications are discussed.
Collapse
Affiliation(s)
- M G Oefelein
- University Hospitals of Cleveland, Department of Urology/Case Western Reserve University, Cleveland, Ohio, USA
| | | | | | | | | |
Collapse
|
39
|
Brown ME, White EM, Feng A. Effects of various treatments on the quantitative recovery of endotoxin from water-soluble metalworking fluids. AIHAJ 2000; 61:517-20. [PMID: 10976681 DOI: 10.1080/15298660008984563] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
Three extraction methods were compared for their effectiveness in the quantitative removal of endotoxin from unused and used bulk water-soluble metalworking fluid (MWF) samples. Soluble, synthetic, and semisynthetic fluids were studied. The three modes of extraction consisted of (1) pyrogen-free water (PFW); (2) PFW and Tween 20 (polyoxyethylene sorbitan monolaurate); and (3) PFW, Tween 20, and sonication. Results suggest that vigorous recovery methods yield higher amounts of endotoxin from MWF samples than mild recovery methods in PFW alone. Additional studies are required to aid in the understanding of the factors that significantly affect endotoxin extraction yields from these fluids.
Collapse
Affiliation(s)
- M E Brown
- US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, OH 45226, USA
| | | | | |
Collapse
|
40
|
Liu S, Yan A, Feng A, Zhang L. [Clinicopathological study of 52 cases of ameloblastoma of jaw]. Zhonghua Bing Li Xue Za Zhi 1999; 28:109-11. [PMID: 11869518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
OBJECTIVE To observe the relationship between the histologic types, tumor invasion, operation mode and recurrence of ameloblastoma. METHODS Using WHO classification (1992) for histological typing of odontogenic tumors, 52 cases of ameloblastoma were studied clinicopathologically. RESULTS The 8 pathological types are: follicle formation type, plexiform type, acanthoma type, basal cell type, granular cell type, desmoplastic ameloblastoma, kerato ameloblastoma and ameloblastoma accompanied by bone formation. Recurrence in the 8 above types following surgery were 5/11, 0/5, 7/15, 5/8, 0/3, 0/3, 2/3 and 1/4 respectively. Five cases recurred in 21 patients with tumor cells infiltrating into the connective tissue surrounding the tumors. 12 cases recurred in 16 patients with tumor cells infiltrating thru the capsule into surrounding soft tissue. The recurrence rate in patients who had their tumor enucleated or curetted was 56.5% (13/23). The recurrence rate in the tumors resected together with involved bone segment was 24.1% (7/29). Multiple recurrences occurred in 3 cases whose tumors were not well differentiated and had atypical cells. CONCLUSIONS Recurrence was more often seen in the follicular, acanthoma, basaloid, and keratoid types of ameloblastoma. When these tumors invade adjacent soft tissues, the recurrence rate is also higher. Recurrence is linked to conservative surgery and to tumors with low differentiation.
Collapse
Affiliation(s)
- S Liu
- Departent of Pathology, Tianjin Cancer Hospital, Tianjin 300060
| | | | | | | |
Collapse
|
41
|
Feng A, Zou H, Zhang B, Wang H, Zhang Y. [Determination of steroids in milk powder and birds' feces by high performance liquid chromatography coupled with evaporative light scattering detector]. Se Pu 1997; 15:102-5. [PMID: 15739391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023] Open
Abstract
In this paper, a new, simple and rapid method for the analysis of steroids by reversed-phase high performance liquid chromatography (HPLC) coupled with evaporative light scattering detector (ELSD) is presented. A good resolution of the 12 steroids is obtained within 35 min with a gradient elution using a binary mobile phase composed of methanol and water. The analytical column used was 2.0mm x 150mm, packed with BDS (particle size 5microm) and the mobile phase flow rate was 0.2mL/min. Nebulizer gas flow rate and drift tube temperature, the two critical parameters for determining the reproducibility and signal-to-noise ratio of ELSD were 2.00mL/min and 95 degrees C, respectively. The response of the ELSD was non-linear as a result of basic light-scattering principles, the calibration curve by plotting lnY vs lnX (Y, X stand for peak area and concentration, respectively) shows a good linearity in the range of 5-50mg/L with a correlation coefficient higher than 0.99 for individual steroid and with relative standard deviation less than 6.92%. This method has been applied to the determination of steroids in milk powder and birds' feces, solid phase extraction on reverse phase bonded C18 (5mL/500mg) was used to treat the samples efficiently. The recoveries of the steroids were between 84.0%-102.8%.
Collapse
Affiliation(s)
- A Feng
- National Chromatographic R. & A. Center, Dalian Institute of Chemical Physics, the Chinese Academy of Sciences, Dalian, 116011
| | | | | | | | | |
Collapse
|
42
|
Schlecht PC, Groff JH, Feng A, Song R. Laboratory and analytical method performance of lead measurements in paint chips, soils, and dusts. Am Ind Hyg Assoc J 1996; 57:1035-43. [PMID: 8931311 DOI: 10.1080/15428119691014378] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The National Lead Laboratory Accreditation Program (NLLAP) recognizes laboratories capable of analyzing lead in paints, soils, and dusts. NLLAP requires successful participation in the Environmental Lead Proficiency Analytical Testing (ELPAT) program. For paint chip analyses, laboratory-to-laboratory variability is about 10% relative standard deviation (RSD) for lead levels near 0.5%, the HUD definition of lead-based paint. For soil analyses, RSDs are about 9 to 10% near relevant federal soil standards and 16% near the lowest state bare soil standard that currently exists. For dust wipe analyses, RSDs range from 10 to 16% for lead levels near relevant HUD standards. Of participating laboratories, 92 to 93% consistently meet ELPAT performance limits. A variety of analytical methods gives similar results. No conclusive significant differences were found among most frequently used hotplate and microwave sample preparation techniques. In addition, several participating laboratories have successfully used ultrasonic extraction methods, a method suitable for use at abatement sites. The three most frequently used instrumental techniques, flame atomic absorption (FAA), inductively coupled plasma-atomic emission spectroscopy (ICP-AES), and graphite furnace atomic absorption show no statistically significant differences in ability to meet ELPAT performance limits. However, small statistically significant biases between these methods sometimes occur. The magnitude of biases is less than 5% of the corresponding laboratory mean near relevant federal standards except for lead levels near the lowest HUD lead wipe standard, where biases can be as high as 8%. Other instrumental methods that have been used successfully include ICP-mass spectroscopy, direct current plasma-atomic emission spectroscopy, dithizone spectrophotometry, and anodic stripping voltametry.
Collapse
Affiliation(s)
- P C Schlecht
- Department of Health and Human Services, Centers for Disease Control and Prevention, Robert A. Taft Laboratories, Cincinnati, OH 45226, USA
| | | | | | | |
Collapse
|
43
|
|
44
|
Wang C, Feng A, Binglin G, Fusui L, Chen Y. Electronic structure of the light-impurity (boron)-vacancy complex in iron. Phys Rev B Condens Matter 1988; 38:3905-3912. [PMID: 9946762 DOI: 10.1103/physrevb.38.3905] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|